文献速递肝病消化道肿瘤与早癌

MYC决定KRAS驱动原发性肝癌发展中的谱系定向

MYC determines lineage commitment in KRAS-driven primary liver cancer development.
PubMed 文献 · J Hepatol · 2023-03-09

本研究通过跨物种转录组与表观遗传分析及小鼠模型功能验证,发现FOXA1/FOXA2是MYC依赖的肝细胞癌谱系决定因子,ETS1是肝内胆管癌谱系决定因子且被MYC抑制;抑制FOXA1/FOXA2并表达ETS1可使肝细胞癌完全转为肝内胆管癌。

要点

  • MYC是肝细胞癌与肝内胆管癌谱系定向的关键决定因子。
  • FOXA1/FOXA2为MYC依赖的肝细胞癌谱系决定因子。
  • ETS1为肝内胆管癌谱系决定因子,在肝细胞癌发生中被MYC抑制。

核心结论

  • 数据确立MYC为原发性肝癌谱系定向的关键决定因子,并解释酒精性或非酒精性脂肪性肝炎等肝损伤风险因素可导致肝细胞癌或肝内胆管癌。

研究设计与样本

  • 对小鼠肝细胞癌和肝内胆管癌及两个人原发性肝癌队列进行跨物种转录组和表观遗传分析。
  • 整合数据分析包括转录组数据的表观遗传景观计算机删除分析(LISA)和染色质可及性数据的超几何优化基序富集分析(HOMER)。
  • 候选基因在非种系基因工程原发性肝癌小鼠模型中进行功能遗传测试(shRNAmir敲低或全长cDNA过表达)。

主要发现

  • 整合生物信息学分析确定叉头家族转录因子FOXA1和FOXA2为MYC依赖的肝细胞癌谱系决定因子。
  • ETS家族转录因子ETS1被确定为肝内胆管癌谱系决定因子,在肝细胞癌发展中被MYC抑制。
  • shRNA介导的FOXA1和FOXA2抑制伴随ETS1表达在原发性肝癌小鼠模型中使肝细胞癌完全转为肝内胆管癌发展。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Primary liver cancer (PLC) comprises hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (iCCA), two frequent and lethal tumour types that differ regarding their tumour biology and responses to cancer therapies. Liver cells harbour a high degree of cellular plasticity and can give rise to either HCC or iCCA. However, little is known about the cell-intrinsic mechanisms directing an oncogenically transformed liver cell to either HCC or iCCA. The scope of this study was to identify cell-intrinsic factors determining lineage commitment in PLC. METHODS: Cross-species transcriptomic and epigenetic profiling was applied to murine HCCs and iCCAs and to two human PLC cohorts. Integrative data analysis comprised epigenetic Landscape In Silico deletion Analysis (LISA) of transcriptomic data and Hypergeometric Optimization of Motif EnRichment (HOMER) analysis of chromatin accessibility data. Identified candidate genes were subjected to functional genetic testing in non-germline genetically engineered PLC mouse models (shRNAmir knockdown or overexpression of full-length cDNAs). RESULTS: Integrative bioinformatic analyses of transcriptomic and epigenetic data pinpointed the Forkhead-family transcription factors FOXA1 and FOXA2 as MYC-dependent determination factors of the HCC lineage. Conversely, the ETS family transcription factor ETS1 was identified as a determinant of the iCCA lineage, which was found to be suppressed by MYC during HCC development. Strikingly, shRNA-mediated suppression of FOXA1 and FOXA2 with concomitant ETS1 expression fully switched HCC to iCCA development in PLC mouse models. CONCLUSIONS: The herein reported data establish MYC as a key determinant of lineage commitment in PLC and provide a molecular explanation why common liver-damaging risk factors such as alcoholic or non-alcoholic steatohepatitis can lead to either HCC or iCCA. IMPACT AND IMPLICATIONS: Liver cancer is a major health problem and comprises hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (iCCA), two frequent and lethal tumour types that differ regarding their morphology, tumour biology, and responses to cancer therapies. We identified the transcription factor and oncogenic master regulator MYC as a switch between HCC and iCCA development. When MYC levels are high at the time point when a hepatocyte becomes a tumour cell, an HCC is growing out. Conversely, if MYC levels are low at this time point, the result is the outgrowth of an iCCA. Our study provides a molecular explanation why common liver-damaging risk factors such as alcoholic or non-alcoholic steatohepatitis can lead to either HCC or iCCA. Furthermore, our data harbour potential for the development of better PLC therapies.

来源:J Hepatol,查看原文。版权归原作者所有。

引用

  1. D'Artista L, Moschopoulou AA, Barozzi I, et al. MYC determines lineage commitment in KRAS-driven primary liver cancer development. J Hepatol. 2023. PMID: 36906109. doi:10.1016/j.jhep.2023.02.039

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。